Production-grade Biopharmaceutical Equipment Market Report – Research, Industry Analysis Reports and Market Demands

Global Production-grade Biopharmaceutical Equipment Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

2 Company Profiles

3 Market Competition, by Players

3.1 Global Production-grade Biopharmaceutical Equipment Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Production-grade Biopharmaceutical Equipment by Company Revenue
- 3.2.2 Top 3 Production-grade Biopharmaceutical Equipment Players Market Share in 2025
- 3.2.3 Top 6 Production-grade Biopharmaceutical Equipment Players Market Share in 2025
3.3 Production-grade Biopharmaceutical Equipment Market: Overall Company Footprint Analysis
- 3.3.1 Production-grade Biopharmaceutical Equipment Market: Region Footprint
- 3.3.2 Production-grade Biopharmaceutical Equipment Market: Company Product Type Footprint
- 3.3.3 Production-grade Biopharmaceutical Equipment Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

4.1 Global Production-grade Biopharmaceutical Equipment Consumption Value and Market Share by Type (2021-2026)
4.2 Global Production-grade Biopharmaceutical Equipment Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

5.1 Global Production-grade Biopharmaceutical Equipment Consumption Value Market Share by Application (2021-2026)
5.2 Global Production-grade Biopharmaceutical Equipment Market Forecast by Application (2027-2032)

6 North America

6.1 North America Production-grade Biopharmaceutical Equipment Consumption Value by Type (2021-2032)
6.2 North America Production-grade Biopharmaceutical Equipment Market Size by Application (2021-2032)
6.3 North America Production-grade Biopharmaceutical Equipment Market Size by Country
- 6.3.1 North America Production-grade Biopharmaceutical Equipment Consumption Value by Country (2021-2032)
- 6.3.2 United States Production-grade Biopharmaceutical Equipment Market Size and Forecast (2021-2032)
- 6.3.3 Canada Production-grade Biopharmaceutical Equipment Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Production-grade Biopharmaceutical Equipment Market Size and Forecast (2021-2032)

7 Europe

7.1 Europe Production-grade Biopharmaceutical Equipment Consumption Value by Type (2021-2032)
7.2 Europe Production-grade Biopharmaceutical Equipment Consumption Value by Application (2021-2032)
7.3 Europe Production-grade Biopharmaceutical Equipment Market Size by Country
- 7.3.1 Europe Production-grade Biopharmaceutical Equipment Consumption Value by Country (2021-2032)
- 7.3.2 Germany Production-grade Biopharmaceutical Equipment Market Size and Forecast (2021-2032)
- 7.3.3 France Production-grade Biopharmaceutical Equipment Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Production-grade Biopharmaceutical Equipment Market Size and Forecast (2021-2032)
- 7.3.5 Russia Production-grade Biopharmaceutical Equipment Market Size and Forecast (2021-2032)
- 7.3.6 Italy Production-grade Biopharmaceutical Equipment Market Size and Forecast (2021-2032)

8 Asia-Pacific

8.1 Asia-Pacific Production-grade Biopharmaceutical Equipment Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Production-grade Biopharmaceutical Equipment Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Production-grade Biopharmaceutical Equipment Market Size by Region
- 8.3.1 Asia-Pacific Production-grade Biopharmaceutical Equipment Consumption Value by Region (2021-2032)
- 8.3.2 China Production-grade Biopharmaceutical Equipment Market Size and Forecast (2021-2032)
- 8.3.3 Japan Production-grade Biopharmaceutical Equipment Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Production-grade Biopharmaceutical Equipment Market Size and Forecast (2021-2032)
- 8.3.5 India Production-grade Biopharmaceutical Equipment Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Production-grade Biopharmaceutical Equipment Market Size and Forecast (2021-2032)
- 8.3.7 Australia Production-grade Biopharmaceutical Equipment Market Size and Forecast (2021-2032)

9 South America

9.1 South America Production-grade Biopharmaceutical Equipment Consumption Value by Type (2021-2032)
9.2 South America Production-grade Biopharmaceutical Equipment Consumption Value by Application (2021-2032)
9.3 South America Production-grade Biopharmaceutical Equipment Market Size by Country
- 9.3.1 South America Production-grade Biopharmaceutical Equipment Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Production-grade Biopharmaceutical Equipment Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Production-grade Biopharmaceutical Equipment Market Size and Forecast (2021-2032)

10 Middle East & Africa

10.1 Middle East & Africa Production-grade Biopharmaceutical Equipment Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Production-grade Biopharmaceutical Equipment Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Production-grade Biopharmaceutical Equipment Market Size by Country
- 10.3.1 Middle East & Africa Production-grade Biopharmaceutical Equipment Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Production-grade Biopharmaceutical Equipment Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Production-grade Biopharmaceutical Equipment Market Size and Forecast (2021-2032)
- 10.3.4 UAE Production-grade Biopharmaceutical Equipment Market Size and Forecast (2021-2032)

11 Market Dynamics

11.1 Production-grade Biopharmaceutical Equipment Market Drivers
11.2 Production-grade Biopharmaceutical Equipment Market Restraints
11.3 Production-grade Biopharmaceutical Equipment Trends Analysis
11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

12.1 Production-grade Biopharmaceutical Equipment Industry Chain
12.2 Production-grade Biopharmaceutical Equipment Upstream Analysis
12.3 Production-grade Biopharmaceutical Equipment Midstream Analysis
12.4 Production-grade Biopharmaceutical Equipment Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology
14.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Production-grade Biopharmaceutical Equipment market size was valued at US$ 14473 million in 2025 and is forecast to a readjusted size of US$ 22035 million by 2032 with a CAGR of 6.4% during review period.
In the biopharmaceutical field, the equipment configuration is most complete and the process requirements are most stringent during the large-scale production stage. Manufacturing activities in this industry typically revolve around "cell or microbial amplification—product expression—harvesting and clarification—purification and refining—concentration and fluid exchange—aseptic assurance and formulation," with production organization exhibiting significant high cleanliness, high consistency, and strong validation attributes. From the perspective of equipment placement, bioreactors, single-use bioreactors, fermenters, and storage systems primarily undertake cell culture or virus amplification tasks in the production of antibody drugs, recombinant protein drugs, and vaccine bulk solutions; depth filtration, centrifuges, TFF systems, chromatography systems, and sterile filtration constitute the main body of downstream purification, used for cell removal, target protein capture, virus removal, concentration, and buffer replacement; and solution preparation systems, online solution preparation, and CIP cleaning systems serve the preparation of culture media, buffers, and formulation solutions, and undertake batch-to-batch switching and validation cleaning tasks. For cell therapy products such as CAR-T, although the overall production volume is smaller than that of monoclonal antibodies, they rely more heavily on closed fluid pathways, aseptic connections, and automated cell processing platforms. For small nucleic acid drugs, the purification and medium-change processes are more sensitive to membrane systems and chromatography platforms. Overall, in the biopharmaceutical field, equipment used in large-scale production and purification stages not only performs manufacturing functions but also serves as the underlying support for drug quality consistency, regulatory compliance, and commercial scale-up.
Changes in the policy environment often create new growth opportunities for industries. Currently, major global economies are placing biomanufacturing on their strategic agendas, and a series of favorable policies are significantly expanding the market space for biomanufacturing equipment. For example, after the outbreak of the pandemic, countries realized the importance of domestic biopharmaceutical production capacity, and governments led or supported the construction of vaccine and biopharmaceutical factories, directly driving large-scale procurement of related equipment. The United States, through legislation such as the National Biomanufacturing Initiative and the CHIPS and Science Act, has invested billions of dollars to strengthen its domestic biotechnology supply chain, not only encouraging companies to increase R&D, but also using some funds directly to purchase key equipment such as advanced bioreactors and aseptic filling equipment. China has introduced industrial policies to support the localization of high-end biopharmaceutical equipment, providing preferential treatment in terms of funding, land use, and taxation, enabling domestic equipment manufacturers to accelerate their growth under the favorable policy environment. For equipment companies, actively positioning themselves in line with these policy directions can fully share in the policy dividends.
The continued high-speed growth of the pharmaceutical sector is paramount: In recent years, the proportion of biopharmaceuticals in the global pharmaceutical market has been continuously increasing, and multiple new therapy pipelines have entered the commercialization stage, generating a large demand for new production capacity. The global market for biopharmaceutical process equipment and consumables is experiencing rapid growth. This rapid growth directly reflects the strong demand for equipment driven by the expansion of downstream biopharmaceutical production capacity. In the coming years, a large number of new antibody drug, vaccine, and gene therapy production lines will be built and put into operation, leading to a steady increase in orders for various fermenters, cell culture systems, and purification equipment. For equipment suppliers, this is the most crucial and sustainable market driver.
This report is a detailed and comprehensive analysis for global Production-grade Biopharmaceutical Equipment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Production-grade Biopharmaceutical Equipment market size and forecasts, in consumption value ($ Million), 2021-2032
Global Production-grade Biopharmaceutical Equipment market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Production-grade Biopharmaceutical Equipment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Production-grade Biopharmaceutical Equipment market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Production-grade Biopharmaceutical Equipment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Production-grade Biopharmaceutical Equipment market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Danaher, Sartorius, Merck KGaA, GEA, ALFA LAVAL, Morimatsu Industry, Sulzer Ltd, Tofflon, SPX Flow, Lisure Science, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Production-grade Biopharmaceutical Equipment market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Raw Material Handling and Preparation Equipment
Material Conveying Equipment
Air Supply Engineering Equipment
Bioreactors and Fermenters
Separation and Purification Equipment
Evaporation and Crystallization Equipment
Drying Equipment
Cleaning Equipment
Others
Market segment by Process
Based on Single-use Process
Based on Reusable Process
Market segment by Bio-fermentation Capacity
≤2000L
2000-5000L
＞5000L
Market segment by Application
Macromolecular Biopharmaceuticals
Small Molecule Chemical Drugs
Market segment by players, this report covers
Danaher
Sartorius
Merck KGaA
GEA
ALFA LAVAL
Morimatsu Industry
Sulzer Ltd
Tofflon
SPX Flow
Lisure Science
AUSTAR Group
Truking Technology
Pierre Guerin
EastBio
Krones AG
ABEC
Flottweg SE
Tomoe
Jiangsu Zhengchang Group
DCI, Inc.
Greatwall Mixers
EKATO
Jiangsu Hanbon
Cotter Brothers Corporation
Holloway America
BHS-Sonthofen GmbH
Actini Group
Shanghai Triowin Intelligent Machinery
YMC CO., LTD.
Ohkawara Kakohki Co., Ltd.
Suntar Environmental Technology
Buss-SMS-Canzler GmbH
TECNIC
Jiangsu Jiuwu Hi-Tech
Hengfengtai
Beijing ChuangXinTongHeng
BIIC Bianchi SpA
Alsys Group
Solaris Biotech
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Production-grade Biopharmaceutical Equipment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Production-grade Biopharmaceutical Equipment, with revenue, gross margin, and global market share of Production-grade Biopharmaceutical Equipment from 2021 to 2026.
Chapter 3, the Production-grade Biopharmaceutical Equipment competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Production-grade Biopharmaceutical Equipment market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Production-grade Biopharmaceutical Equipment.
Chapter 13, to describe Production-grade Biopharmaceutical Equipment research findings and conclusion.

Buy now